Back

Increased all-cause mortality with intensive blood-pressure control in patients with a baseline systolic blood pressure of >=160 mmHg and a Lower Framingham risk score: a cautionary note from SPRINT

28 August 2017 (14:00 - 14:15)
Organised by:
Congress Presentation Part of: Clinical Trial Update 1 Treatment of hypertension ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Tzung-Dau Wang

National Taiwan University Hospital, Taipei (Taiwan)

5 More presentations in this session

Presentation thumbnail
Systolic Blood Pressure Variability and Major Adverse Outcomes in Patients with Atrial Fibrillation: the AFFIRM Study
Associate Professor M. Proietti (Milan, IT)
Slides Video
Presentation thumbnail
Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial
Doctor R. Giugliano (Boston, US)
Slides Video
Presentation thumbnail
The long-term efficacy and safety of short dual antiplatelet therapy
Professor M. Nakamura (Tokyo, JP)
Slides Video
Presentation thumbnail
Mechanisms for the benefit of spironolactone in resistant hypertension in the PATHWAY-2 study
Professor B. Williams (London, GB)
Slides Video
Presentation thumbnail
Aldosterone Lethal Effects Blocked in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-up
Professor F. Beygui (Caen, FR)
Slides Video

Access the full session

Session thumbnail
Clinical Trial Update 1

The Event

Event poster

ESC Congress 2017

28 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
The relationship between blood pressure and mortality in the general population - it is not as simple as one might think - results from 20 years follow-up in the Study of Health in Pomerania
25 April 2024
thumbnail
Congress Session
Hot papers in hypertension 2023/2024
1 September 2024
thumbnail
Congress Presentation
Heart failure events in a clinical trial of arterial hypertension. The acquittal of the SPRINT trial.
31 August 2020
thumbnail
Congress Presentation
Reduction in blood pressure following renal denervation for patients with differing baseline cardiovascular risk
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources